Deletion of ADAM-9 in HGF/CDK4 mice impairs melanoma development and metastasis

miR-203 Suppresses the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting Oncogene ADAM9 and Oncogenic Long Non-coding RNA HULC

(2016) Daiwei Wan et al.   Anti-Cancer Agents in Medicinal Chemistry

ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells

(2016) Kelli Cristina Micocci et al.   BIOCHIMIE

Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis

(2016) Boris Strilic et al.   NATURE

ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor–initiating cells

(2015) Susobhan Sarkar et al.   NEURO-ONCOLOGY

MiR-33a suppresses breast cancer cell proliferation and metastasis by targeting ADAM9 and ROS1

(2015) Chuankai Zhang et al.   Protein & Cell

ADAM9 Promotes Lung Cancer Metastases to Brain by a Plasminogen Activator-Based Pathway

(2014) C.-Y. Lin et al.   CANCER RESEARCH

Fisetin suppresses ADAM9 expression and inhibits invasion of glioma cancer cells through increased phosphorylation of ERK1/2

(2014) Chien-Min Chen et al.   TUMOR BIOLOGY

miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma

(2013) Nadia Felli et al.   PLoS One

Stromal Fibroblast–Specific Expression of ADAM-9 Modulates Proliferation and Apoptosis in Melanoma Cells In Vitro and In Vivo

(2012) Anna N. Abety et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form

(2010) C. Mongaret et al.   INTERNATIONAL JOURNAL OF CANCER

Increased Expression of a Disintegrin and Metalloprotease-9 in Hepatocellular Carcinoma: Implications for Tumor Progression and Prognosis

(2010) K. Tao et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

The Disintegrin-like and Cysteine-rich domains of ADAM-9 Mediate Interactions between Melanoma Cells and Fibroblasts

(2010) Paola Zigrino et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Autochthonous primary and metastatic melanomas in Hgf-Cdk4R24C mice evade T-cell-mediated immune surveillance

(2010) Jennifer Landsberg et al.   Pigment Cell & Melanoma Research

RNAi-mediated ADAM9 gene silencing inhibits metastasis of adenoid cystic carcinoma cells

(2010) Qin Xu et al.   TUMOR BIOLOGY

Loss of the Metalloprotease ADAM9 Leads to Cone-Rod Dystrophy in Humans and Retinal Degeneration in Mice

(2009) David A. Parry et al.   AMERICAN JOURNAL OF HUMAN GENETICS

ADAM9 Is Involved in Pathological Retinal Neovascularization

(2009) V. Guaiquil et al.   MOLECULAR AND CELLULAR BIOLOGY

Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications

(2009) Erika L Abel et al.   Nature Protocols

Metastatic Cancer Cell

(2008) Marina Bacac et al.   Annual Review of Pathology-Mechanisms of Disease

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression

(2008) Florian R Fritzsche et al.   BMC CANCER

Laminin-332-Integrin Interaction: A Target For Cancer Therapy?

(2008) Daisuke Tsuruta et al.   CURRENT MEDICINAL CHEMISTRY

The ADAM metalloproteinases

(2008) D EDWARDS et al.   MOLECULAR ASPECTS OF MEDICINE

Magnetic Resonance Imaging of Endothelial Adhesion Molecules in Mouse Atherosclerosis Using Dual-Targeted Microparticles of Iron Oxide

(2007) Martina A. McAteer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Emerging roles of ADAM and ADAMTS metalloproteinases in cancer

(2007) N. Rocks et al.   BIOCHIMIE

Bridging structure with function: Structural, regulatory, and developmental role of laminins

(2007) Julia Tzu et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY